Protocol for a randomized controlled trial of a resistance exercise training to treat major depression via cerebrovascular mechanisms (RESIST Trial)

作者
Jacob D. Meyer,Seana L. Smith,John M. Gidley,Abigail Molina,Sydney L. Churchill,Shania J.E. Kelly,Jeni E. Lansing,Nathaniel G. Wade,Alison L. Phillips,Peng Liu,Matthew Payton Herring,Thomas A. Murray,Jill Nicole Barnes,Simon Benjamin Goldberg,Wesley K. Lefferts
出处
期刊:Trials [Springer Science+Business Media]
卷期号:26 (1): 306-306
标识
DOI:10.1186/s13063-025-09025-z
摘要

BACKGROUND: Many adults with major depressive disorder (MDD) do not engage in treatment and may also not respond when current frontline treatments are completed. Resistance exercise training (RET) is an understudied behavioral treatment option, which may help with MDD management through improving cerebral blood flow that is commonly impaired in adults with MDD. The purpose of this study is to use gold-standard research methods to determine the validity (clinical efficacy) of RET for treating MDD and to determine potential cerebrovascular pathways through which RET might improve MDD symptoms. METHODS: This study will be a randomized controlled trial of 200 adults with DSM-5-diagnosed MDD of at least mild severity. Participants will be randomized to 16 weeks of twice-weekly RET at either guidelines-based high dose (60% one-repetition maximum initial load; n = 100) or a low-dose/SHAM (30% one-repetition maximum initial load; n = 100) progressive, upper- and lower-body program using resistance machines. The primary clinical outcomes of this trial are depressive symptom severity, assessed via clinician-rated GRID-Hamilton Depression Rating Scale and self-reported Quick Inventory of Depressive Symptomatology. Secondary outcomes that will examine potential mediators are cerebral blood flow (via cerebral blood velocity and pulsatility) and self-efficacy (via New General Self-Efficacy Scale and RET Task Self-Efficacy). Group differences will be evaluated during assessment visits at weeks 0 (Baseline), 8, 16 (Post-Intervention), 26, and 52. Additional analyses will explore predictors of treatment success and participants' maintenance of the RET past the active intervention. DISCUSSION: RET is an understudied behavioral treatment for MDD. This randomized controlled trial will critically build on previous studies by using a large sample size, rigorously examining potential (provocative, plausible) biological and psychological mechanisms of RET's hypothesized antidepressant effects, and determining potential persistent effects with short- and long-term follow-up assessments. If clinical efficacy is confirmed, RET would be added as a highly translatable, accessible, low-cost alternative treatment option for individuals with MDD. Further effectiveness and implementation research would be required if efficacy is confirmed in this trial. TRIAL REGISTRATION: This trial is registered on ClinicaTrials.gov (ID: NCT06110897; October 20th, 2023; https://clinicaltrials.gov/study/NCT06110897 ).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
1秒前
FashionBoy的应助被派大星采纳,获得10
1秒前
bkagyin的应助被明理的千筹采纳,获得100
1秒前
bkagyin的应助被羊咩咩采纳,获得10
1秒前
chenwudu发布了新的文献求助10
1秒前
Tongtong发布了新的文献求助10
2秒前
2秒前
解源完成签到,获得积分10
2秒前
天真依白发布了新的文献求助10
3秒前
3秒前
fdpb完成签到,获得积分10
3秒前
wsj完成签到 ,获得积分10
3秒前
篝火完成签到,获得积分20
4秒前
4秒前
4秒前
SJXS完成签到,获得积分10
5秒前
二手的科学家完成签到,获得积分10
5秒前
lcl发布了新的文献求助10
5秒前
完美冷安完成签到,获得积分10
5秒前
hua发布了新的文献求助10
5秒前
111发布了新的文献求助10
5秒前
5秒前
5秒前
FOB发布了新的文献求助10
6秒前
加点研完成签到,获得积分10
6秒前
6秒前
Fossette发布了新的文献求助10
6秒前
Shirly完成签到,获得积分10
6秒前
7秒前
乐乐的应助被饼饼采纳,获得10
7秒前
7秒前
斯文友安完成签到,获得积分20
7秒前
积极的黑猫完成签到,获得积分10
7秒前
此晴可待发布了新的文献求助10
7秒前
羊三百完成签到 ,获得积分10
7秒前
dinghongzhen发布了新的文献求助20
8秒前
xia完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180927
求助须知:如何正确求助?哪些是违规求助? 9570973
关于积分的说明 21815578
捐赠科研通 7777227
什么是DOI,文献DOI怎么找? 3433367
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479346